Basilea Pharmaceutica AG
BPMUF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $572 | $580 | $543 | $414 |
| - Cash | $128 | $121 | $63 | $60 |
| + Debt | $97 | $112 | $112 | $129 |
| Enterprise Value | $541 | $571 | $593 | $482 |
| Revenue | $104 | $132 | $76 | $73 |
| % Growth | -21.4% | 73.3% | 4.9% | – |
| Gross Profit | $41 | $145 | $25 | $56 |
| % Margin | 39.9% | 109.9% | 32.2% | 76.9% |
| EBITDA | $25 | $56 | $10 | $3 |
| % Margin | 24.1% | 42.5% | 13.3% | 4.3% |
| Net Income | $16 | $57 | $21 | -$21 |
| % Margin | 15.2% | 43% | 27.2% | -29.4% |
| EPS Diluted | 1.26 | 4.2 | 1.5 | -1.78 |
| % Growth | -70% | 180% | 184.3% | – |
| Operating Cash Flow | $23 | $56 | $18 | -$8 |
| Capital Expenditures | -$0 | -$1 | -$0 | -$1 |
| Free Cash Flow | $23 | $55 | $17 | -$8 |